ロード中...
Recombinant biologic products versus nutraceuticals from plants – a regulatory choice?
Biotechnology has transformed the potential for plants to be a manufacturing source of pharmaceutical compounds. Now, with transgenic and transient expression techniques, virtually any biologic, including vaccines and therapeutics, could be manufactured in plants. However, uncertainty over the regul...
保存先:
| 出版年: | Br J Clin Pharmacol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5338133/ https://ncbi.nlm.nih.gov/pubmed/27297459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13041 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|